openPR Logo
Press release

Lucintel Forecasts the Global Liver Cancer Diagnostic Market to Reach $11.0 billion by 2030

09-18-2025 01:42 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Lucintel

Liver Cancer Diagnostic Market

Liver Cancer Diagnostic Market

According to a market report by Lucintel, the future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030 from $7.7 billion in 2024, at a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.
A more than 150-page report to understand trends, opportunity and forecast in liver cancer diagnostic market to 2030 by test type (laboratory tests, imaging, endoscopy, biopsy, and others), end use (hospitals & diagnostic laboratories, academic & research institutes, and pharmaceutical & CRO laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.
Within this market, hospital and diagnostic laboratory will remain the largest segment over the forecast period.
Download sample by clicking on liver cancer diagnostic market
North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.
Abbott Laboratories, F. Hoffmann-La Roche, Qiagen, Thermo Fisher Scientific, Siemens Healthineers are the major suppliers in the liver cancer diagnostic market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Panic Hardware Market
Touchless Biometrics Solutions Market
Voice Biometrics System Market
Audio Visual Hardware Market
Autonomous Vehicle ECU Comprehensive Market

8951 Cypress Waters Blvd, Suite 160 Dallas, TX 75019, USA
Tel: +1-972-636-5056

Lucintel is the one of the world's most reputed market research report company which provides market intelligence services that free up your market research and strategic planning resources (time, money and people) and allows you to focus on your core business. We assist you in the utilization of the best market intelligence for greater business gains and we do it faster, better and cheaper. Lucintel offers unmatched data and report quality as compared to the other market research report companies with highest customer satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucintel Forecasts the Global Liver Cancer Diagnostic Market to Reach $11.0 billion by 2030 here

News-ID: 4187435 • Views:

More Releases from Lucintel

Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 billion by 2030
Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 b …
According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 billion by 2030
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 bil …
According to a market report by Lucintel, the future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 from $5.5 billion in 2024, at a CAGR of 5.5% from 2024 to 2030. The major drivers for
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to Reach $18.1 billion by 2030
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to R …
According to a market report by Lucintel, the future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030 from $13.5 billion in 2024, at a CAGR of 5.0% from 2024 to 2030. The major drivers for this market are increasing government initiatives
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 billion by 2030
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 bil …
According to a market report by Lucintel, the future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.3 billion by 2030 from $1.5 billion in 2024, at a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing prevalence

All 5 Releases


More Releases for Liver

Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Liver Metastases Treatment Market Size By 2025? The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health. ● Product Name - LivCare
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production